Wikidata entity: Q3791612
C₂₀H₃₆N₂O₃S (P274)
Quantities
| P4250 | defined daily dose | 1 |
| P2067 | mass | 384.244664 |
| P3780 | active ingredient in | ... | Q47521410 (Corvert) | Corvert |
| P233 | canonical SMILES | String | CCCCCCCN(CC)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2175 | medical condition treated | ... | Q815819 (atrial fibrillation) | atrial fibrillation |
| P129 | physically interacts with | ... | Q905000 (Potassium voltage-gated channel subfamily H member 2) | Potassium voltage-gated channel subfamily H member 2 |
| P769 | significant drug interaction | ... | Q7739 (arsenic trioxide) | arsenic trioxide |
| P769 | significant drug interaction | ... | Q41576 (cocaine) | cocaine |
| P769 | significant drug interaction | ... | Q58375 (thioridazine) | thioridazine |
| P769 | significant drug interaction | ... | Q118551 (clarithromycin) | clarithromycin |
| P769 | significant drug interaction | ... | Q144085 (pimozide) | pimozide |
| P769 | significant drug interaction | ... | Q165399 (azithromycin) | azithromycin |
| P769 | significant drug interaction | ... | Q174259 (droperidol) | droperidol |
| P769 | significant drug interaction | ... | Q179996 ((RS)-methadone) | (RS)-methadone |
| P769 | significant drug interaction | ... | Q213511 (erythromycin) | erythromycin |
| P769 | significant drug interaction | ... | Q251347 (haloperidol) | haloperidol |
| P769 | significant drug interaction | ... | Q407972 (chlorpromazine) | chlorpromazine |
| P769 | significant drug interaction | ... | Q408163 (anagrelide) | anagrelide |
| P769 | significant drug interaction | ... | Q408637 (dronedarone) | dronedarone |
| P769 | significant drug interaction | ... | Q410061 (amiodarone) | amiodarone |
| P769 | significant drug interaction | ... | Q412496 (quinidine) | quinidine |
| P769 | significant drug interaction | ... | Q413591 (sotalol) | sotalol |
| P769 | significant drug interaction | ... | Q409672 ((RS)-citalopram) | (RS)-citalopram |
| P769 | significant drug interaction | ... | Q410011 (ondansetron) | ondansetron |
| P769 | significant drug interaction | ... | Q416206 (pentamidine) | pentamidine |
| P769 | significant drug interaction | ... | Q417597 (procainamide) | procainamide |
| P769 | significant drug interaction | ... | Q417909 (terfenadine) | terfenadine |
| P769 | significant drug interaction | ... | Q419394 (sevoflurane) | sevoflurane |
| P769 | significant drug interaction | ... | Q421381 (flecainide) | flecainide |
| P769 | significant drug interaction | ... | Q422418 ((RS)-sulpiride) | (RS)-sulpiride |
| P769 | significant drug interaction | ... | Q422438 (chloroquine) | chloroquine |
| P769 | significant drug interaction | ... | Q423437 (astemizole) | astemizole |
| P769 | significant drug interaction | ... | Q423757 (escitalopram) | escitalopram |
| P769 | significant drug interaction | ... | Q424238 (domperidone) | domperidone |
| P769 | significant drug interaction | ... | Q424940 (moxifloxacin) | moxifloxacin |
| P769 | significant drug interaction | ... | Q425120 (disopyramide) | disopyramide |
| P769 | significant drug interaction | ... | Q425295 (cisapride) | cisapride |
| P769 | significant drug interaction | ... | Q947595 (halofantrine) | halofantrine |
| P769 | significant drug interaction | ... | Q976559 (sparfloxacin) | sparfloxacin |
| P769 | significant drug interaction | ... | Q3712521 (dofetilide) | dofetilide |
| P769 | significant drug interaction | ... | Q4890934 (bepridil) | bepridil |
| P769 | significant drug interaction | ... | Q6821618 (mesoridazine) | mesoridazine |
| P769 | significant drug interaction | ... | Q10354103 (probucol) | probucol |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q241549 (antiarrhythmic agent) | antiarrhythmic agent |
| P267 | ATC code | C01BD05 |
| P231 | CAS Registry Number | 122647-31-8 |
| P683 | ChEBI ID | 5856 |
| P592 | ChEMBL ID | CHEMBL533 |
| P661 | ChemSpider ID | 54755 |
| P715 | DrugBank ID | DB00308 |
| P11198 | DrugCentral ID | 1412 |
| P8494 | DSSTOX compound identifier | DTXCID30197270 |
| P3117 | DSSTox substance ID | DTXSID20861271 |
| P646 | Freebase ID | /m/0h07s2 |
| P595 | Guide to Pharmacology Ligand ID | 7200 |
| P2057 | Human Metabolome Database ID | HMDB0014453 |
| P234 | InChI | InChI=1S/C20H36N2O3S/c1-4-6-7-8-9-16-22(5-2)17-10-11-20(23)18-12-14-19(15-13-18)21-26(3,24)25/h12-15,20-21,23H,4-11,16-17H2,1-3H3 |
| P235 | InChIKey | ALOBUEHUHMBRLE-UHFFFAOYSA-N |
| P665 | KEGG ID | C07753 |
| P665 | KEGG ID | D08060 |
| P486 | MeSH descriptor ID | C067192 |
| P6366 | Microsoft Academic ID (discontinued) | 2779215400 |
| P2115 | NDF-RT ID | N0000022023 |
| P10283 | OpenAlex ID | C2779215400 |
| P11199 | Probes And Drugs ID | PD010110 |
| P662 | PubChem CID | 60753 |
| P3345 | RxNorm CUI | 41289 |
| P2877 | SureChEMBL ID | 3719856 |
| P2892 | UMLS CUI | C0082966 |
| P11089 | UniChem compound ID | 543301 |
| P652 | UNII | 2436VX1U9B |
| P11143 | WikiProjectMed ID | Ibutilide |
Why not click here or view trends?
log id: 2698444